Study viral levels in blood and lymph node tissue with HIV
Part of Immune system & allergy, Infections clinical trials.
This study measures how much HIV is in your blood and lymph node tissue. If you qualify, you would also allow blood and other tests (including genetic and hepatitis screening), which may help researchers better understand how HIV affects the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and able to sign written consent.
- Your HIV status must be confirmed with blood testing (ELISA plus another confirmation) or a blood viral load test.
- Your blood test results need to meet specific levels for white blood cells, clotting tests, anemia, and platelets.
- You must have a lymph node that can be felt on exam and is in a place the team can safely access for a biopsy.
- You must be willing to let blood samples be used for future HIV studies, genetic testing (including HLA), and hepatitis screening.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study collects blood cells from people recently diagnosed with HIV who haven't started HIV medicines yet. Researchers use these samples to understand how HIV affects the immune system and develop better treatments.
This study tests how well researchers can track HIV-related health and immune changes over time by collecting blood and other samples. It may help you and your care team by creating detailed monitoring, even if your HIV diagnosis is new or still being evaluated.
This research study examines how HIV works in the blood and body fluids of people with and without HIV. By studying blood samples, researchers hope to better understand HIV infection and develop better treatments.
This research study collects blood cells from adults with HIV and their family members to understand why some people's immune systems control HIV better than others. Researchers will use your cells to study HIV immunity and develop better treatments.
This study collects tissue and blood samples from people who have or have been exposed to certain viruses (HIV, KSHV, HPV, EBV, or HTLV-1) or who have developed cancer or precancerous skin lesions. The samples help researchers understand how these viruses may lead to cancer.
This study uses a small tissue sample from an often-accessible lymph node to learn how HIV affects the body. It may help researchers understand why some people control HIV better than others.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.